Paper39301658
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).
Qu P and 10 others. Int J Mol Med, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review). Papers, record 39301658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39301658
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| Histones | Major topic |
| Epigenesis, Genetic | Major topic |
| Humans | |
| Animals | |
| Methylation | |
| Protein Processing, Post-Translational | |
| Histone Code |
Source PubMed
References161
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35918708 | Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation. | J Biol Eng | 2022 | https://conductscience.org/library/papers/35918708 | PubMed |
| 2 | 26534922 | The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. | J Am Soc Nephrol | 2016 | https://conductscience.org/library/papers/26534922 | PubMed |
| 3 | 37166978 | Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37166978 | PubMed |
| 4 | 28450737 | Writing, erasing and reading histone lysine methylations. | Exp Mol Med | 2017 | https://conductscience.org/library/papers/28450737 | PubMed |
| 5 | 31367244 | A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. | Theranostics | 2019 | https://conductscience.org/library/papers/31367244 | PubMed |
| 6 | 26444031 | Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression. | Kidney Int | 2016 | https://conductscience.org/library/papers/26444031 | PubMed |
| 7 | 29361307 | Renal tubule injury: a driving force toward chronic kidney disease. | Kidney Int | 2018 | https://conductscience.org/library/papers/29361307 | PubMed |
| 8 | 31917689 | Regeneration after acute kidney injury requires PTIP-mediated epigenetic modifications. | JCI Insight | 2020 | https://conductscience.org/library/papers/31917689 | PubMed |
| 9 | 38897443 | The landscape of histone modification in organ fibrosis. | Eur J Pharmacol | 2024 | https://conductscience.org/library/papers/38897443 | PubMed |
| 10 | 31866860 | Histone Methyltransferases as Therapeutic Targets for Kidney Diseases. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31866860 | PubMed |
| 11 | 37105173 | Polycomb Ezh1 maintains murine muscle stem cell quiescence through non-canonical regulation of Notch signaling. | Dev Cell | 2023 | https://conductscience.org/library/papers/37105173 | PubMed |
| 12 | 33639232 | Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33639232 | PubMed |
| 13 | 22473383 | Histone methylation: a dynamic mark in health, disease and inheritance. | Nat Rev Genet | 2012 | https://conductscience.org/library/papers/22473383 | PubMed |
| 14 | 39073023 | Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesis. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/39073023 | PubMed |
| 15 | 34508249 | The Mesangial cell - the glomerular stromal cell. | Nat Rev Nephrol | 2021 | https://conductscience.org/library/papers/34508249 | PubMed |
| 16 | 18598942 | Menin critically links MLL proteins with LEDGF on cancer-associated target genes. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18598942 | PubMed |
| 17 | 33035459 | Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/33035459 | PubMed |
| 18 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 19 | 23200123 | Histone lysine methylation dynamics: establishment, regulation, and biological impact. | Mol Cell | 2012 | https://conductscience.org/library/papers/23200123 | PubMed |
| 20 | 38298064 | Development of Complementary Photo-arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38298064 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42756949 | Epigenetic strategies for mitigating kidney fibrosis. | PeerJ | 2026 | https://conductscience.org/library/papers/42756949 | PubMed |
| 42554966 | Deubiquitinase USP7 stabilizes the histone demethylase KDM5B and promotes the progression of renal fibrosis through the TSC1/mTOR axis. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42554966 | PubMed |
| 42416898 | Regulatory networks of post-translational modifications in diabetic kidney disease: from pathogenic mechanisms to therapeutic frontiers. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42416898 | PubMed |
| 42318940 | Effects of exercise‑derived extracellular vesicles: Epigenetic regulatory mechanisms and protective roles (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42318940 | PubMed |
| 41992968 | Glycolytic lactylation modulates cell death decisions in diabetic kidney disease: Metabolic‑epigenetic interplay between ferroptosis and autophagy in fibrotic remodeling (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41992968 | PubMed |
| 41845912 | Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. | Ren Fail | 2026 | https://conductscience.org/library/papers/41845912 | PubMed |
| 41782138 | The role of histone methylation in fibrosis and its therapeutic potential. | J Transl Med | 2026 | https://conductscience.org/library/papers/41782138 | PubMed |
| 41685570 | Post‑translational modifications in diabetic kidney disease (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41685570 | PubMed |
| 41585789 | Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41585789 | PubMed |
| 41540054 | Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactate. | Nat Commun | 2026 | https://conductscience.org/library/papers/41540054 | PubMed |
| 40828784 | Role of nuclear receptors, lipid metabolism, and mitochondrial function in the pathogenesis of diabetic kidney disease. | Am J Physiol Renal Physiol | 2025 | https://conductscience.org/library/papers/40828784 | PubMed |
| 40682843 | Protective effect of exercise on metabolic dysfunction‑associated fatty liver disease: Potential epigenetic mechanisms (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40682843 | PubMed |
| 40564143 | Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update. | Biomedicines | 2025 | https://conductscience.org/library/papers/40564143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39301658
GET https://conductscience.org/api/papers/v1/39301658/references?page=2